BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/10/2021 6:48:42 AM | Browse: 613 | Download: 1345
 |
Received |
|
2021-04-07 14:52 |
|
Peer-Review Started |
|
2021-04-07 14:57 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-27 20:38 |
|
Revised |
|
2021-05-28 07:15 |
|
Second Decision |
|
2021-07-15 03:25 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-07-15 09:01 |
|
Articles in Press |
|
2021-07-15 09:01 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-25 23:38 |
|
Typeset the Manuscript |
|
2021-08-09 03:38 |
|
Publish the Manuscript Online |
|
2021-08-10 06:48 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Clinical efficacy of antiviral therapy in patients with hepatitis B-related cirrhosis after transjugular intrahepatic portosystemic shunt
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xin Yao, Shan Huang, Hao Zhou, Shan-Hong Tang and Jian-Ping Qin |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jian-Ping Qin, MD, Doctor, Doctor, Department of Gastroenterology, General Hospital of Western Theater Command, No. 270 Rongdu Road, Chengdu 610083, Sichuan Province, China. jpqqing@163.com |
| Key Words |
Transjugular intrahepatic portosystemic shunt; Hypertension; Antiviral; Hepatitis B-related cirrhosis; Liver reserve function |
| Core Tip |
As a big country of hepatitis B, China has about 86 million cases of hepatitis B virus (HBV) infection, ranking the first in the world. Hepatitis B cirrhosis complicated with portal hypertension is characterized by persistent HBV replication and aggravated liver inflammation and fibrosis. Considering the fact that there is no report on the clinical efficacy of antiviral therapy for patients with hepatitis B cirrhosis after transjugular intrahepatic portosystemic shunt at home and abroad, the author’s team believes that this study has certain clinical reference value for the selection of anti-HBV drugs in such patients. |
| Publish Date |
2021-08-10 06:48 |
| Citation |
Yao X, Huang S, Zhou H, Tang SH, Qin JP. Clinical efficacy of antiviral therapy in patients with hepatitis B-related cirrhosis after transjugular intrahepatic portosystemic shunt. World J Gastroenterol 2021; 27(30): 5088-5099 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i30/5088.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i30.5088 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
